Pen Needles Market - Trends & Global Forecasts to 2021

  • ID: 3766877
  • Report
  • Region: Global
  • 186 Pages
  • Markets and Markets
1 of 5
The Pen Needles Market is Projected to Reach USD 2.81 Billion by 2021 from USD 1.65 billion in 2016, Growing at a CAGR of 11.2%

FEATURED COMPANIES

  • Allison Medical, Inc.
  • Artsana S.P.A.
  • B. Braun Melsungen
  • Htl-Strefa S.A.
  • Novo Nordisk A/S
  • Owen Mumford, Ltd.
  • MORE

Over the years, the pen needles market has witnessed various technological advancements in order to cater to the growing demand for safety injections in the healthcare industry. These advancements have led to the development of safety pen needles with an aim to reduce pain, increase comfort, and most importantly reduce needlestick injuries (NSIs). Other factors contributing to the growth of the pen needles market include favorable reimbursement environment and government support in selected countries, advantages of insulin pens over syringes and vials, and growing diabetic population.

The standard pen needles segment is expected to account for the largest share of the pen needles market, by type, in 2016. Increasing diabetic population, rising awareness about the use of pen needles for insulin administration, favorable reimbursement scenario in selected countries, and low costs as compared to safety pen needles are major factors driving the market for standard pen needles. The 8mm pen needles segment is expected to account for the largest share of the pen needles market, by needle length, in 2016. These pen needles are the most prescribed/preferred as they can be conveniently used on normal as well as obese adult patients.

The insulin therapy segment is expected to dominate the pen needles market, by therapy, in 2016. Growth in the insulin therapy segment can be attributed to the increasing use of insulin by the diabetic population and increasing awareness about insulin self-administration among type 1 and type 2 diabetes patients. The retail mode of purchase segment is expected to dominate the pen needles market, by mode of purchase, in 2016. The large share of this segment can mainly be attributed to the increasing purchase of pen needles directly by customers at pharmacies, retail stores, mail orders, and online through websites. Retail stores offer significant discounts on online/retail purchases and provide convenience to customers.

Europe is expected to account for the largest share in the pen needles market in 2016, followed by North America, Asia, and the Rest of the World (RoW). The large share of the European region can be attributed to EU’s Directive on the prevention of sharp injuries in hospitals and the healthcare sector; regulatory frameworks to minimize needlestick injuries & boost the use of safety-engineered devices; high diabetes prevalence and favorable reimbursement for pen needles in Germany; activities to pool funds for diabetes care & research in the U.K.; high insurance coverage and increase in aging population and affordability in France; awareness campaigns for diabetes in Italy; large pool of diabetic population and regulations mandating the use of safety pen needles in Spain; and high diabetes prevalence in Russia, Poland, Romania, and Ukraine. Asia is expected to witness the highest growth rate in the forecast period, mainly due to the rapidly growing diabetic population, increasing awareness, and rising adoption of pen devices for insulin delivery.

The global pen needles market witnesses high competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (new product launches, acquisitions, and geographical expansions) to increase their market shares and to establish a strong foothold in the global market. .

Prominent players in the pen needles market include Becton, Dickinson, and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holdings AG (Switzerland), Owen Mumford, Ltd. (U.K.), HTL-STREFA S.A. (Poland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), UltiMed, Inc. (U.S.), Allison Medical, Inc. (U.S.), and Artsana S.p.a. (Italy).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. The report provides insights on the following pointers:

  •  Market Penetration: Comprehensive information on the product portfolios of the top players in the pen needle market. The report analyzes the market based on type, needle length, therapy, and mode of purchase
  •  Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the pen needle market
  •  Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various pen needles across regions
  •  Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the pen needles market
  •  Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the pen needles market
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Allison Medical, Inc.
  • Artsana S.P.A.
  • B. Braun Melsungen
  • Htl-Strefa S.A.
  • Novo Nordisk A/S
  • Owen Mumford, Ltd.
  • MORE
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered For The Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary And Primary Research Methodology
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Research Design
2.5 Market Data Validation And Triangulation
2.6 Assumptions For The Study

3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights
4.1 Pen Needles Market Overview
4.2 Geographic Analysis: Pen Needles Market, By Length
4.3 Pen Needles Market, By Type
4.4 Pen Needles Market, By Length
4.5 Pen Needles Market, By Mode Of Purchase
4.6 Geographic Snapshot: Pen Needles Market

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Favorable Reimbursement Environment And Government Support In Selected Countries
5.3.1.2 Advantages Of Insulin Pens Over Syringes And Vials
5.3.1.3 Technological Advancements
5.3.1.4 Growing Diabetic Population
5.3.1.5 Conferences, Meetings, And Congresses To Create Pen Needle Awareness
5.3.2 Restraints
5.3.2.1 Poor Reimbursement Structure In Developing Countries
5.3.2.2 Needle Anxiety
5.3.2.3 Alternative Drug Delivery Methods
5.3.2.3.1 Oral Diabetic Agents And Oral Insulin
5.3.2.3.2 Inhalable Insulin
5.3.2.3.3 Nanotechnology To Aid In Transdermal And Inhalational Route Of Administering Proteins And Peptides
5.3.2.4 Severe Shortage Of Endocrinologists In The U.S.
5.3.2.5 Reuse Of Pen Needles
5.3.3 Opportunities
5.3.3.1 Safety Needles
5.3.3.2 Glp-1 Analogues
5.3.4 Challenges
5.3.4.1 Minimizing The Reuse Of Standard Pen Needles
5.3.4.2 Resistance Against Switching From Conventional Devices To Advanced Devices

6 Industry Insights
6.1 Introduction
6.2 Porter’S Five Forces Analysis
6.2.1 Threat Of New Entrants
6.2.2 Bargaining Power Of Suppliers
6.2.3 Bargaining Power Of Buyers
6.2.4 Segment Rivalry
6.2.5 Threat Of Substitutes
6.3 Competitive Intensity
6.3.1 Evaluation Parameters
6.3.2 Scoring Methodology
6.3.3 Competitive Intensity Score, By Company
6.3.3.1 Competitive Intensity Score For Bd
6.3.3.2 Competitive Intensity Score For Novo Nordisk
6.3.3.3 Competitive Intensity Score For Ypsomed
6.3.4 Competitive Intensity Mapping Of Bd, Novo Nordisk, And Ypsomed
6.3.5 Comparison Of Evaluation Parameters, By Company
6.3.5.1 Pricing
6.3.5.2 Product Portfolio
6.3.5.3 Product Launches/Technological Advancements
6.3.5.4 Production Capacity (2015)
6.3.5.5 Geographical Presence
6.3.5.6 Promotional/Marketing Activities
6.3.5.7 Sponsorships/Donations/Education/Awareness Campaigns
6.3.5.8 M&As, Partnerships, Collaborations, Agreements, And Expansions
6.3.5.9 Years Of Experience
6.3.5.10 Certifications/Accreditations/Awards

7 Pen Needles Market, By Type
7.1 Introduction
7.2 Standard Pen Needles
7.3 Safety Pen Needles

8 Pen Needles Market, By Needle Length
8.1 Introduction
8.2 4Mm
8.3 5Mm
8.4 6Mm
8.5 8Mm
8.6 10Mm
8.7 12Mm

9 Pen Needles Market, By Therapy
9.1 Introduction
9.2 Insulin
9.3 Glp-1
9.4 Growth Hormones

10 Pen Needles Market, By Mode Of Purchase
10.1 Introduction
10.2 Retail
10.3 Non-Retail

11 Pen Needles Market, By Region
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.1.1 Growing Diabetes Prevalence And Favorable Reimbursement Scenario For Pen Needles
11.2.1.2 Federal Initiatives To Stimulate The U.S. Pen Needles Market
11.2.1.3 Focus Of Leading Players On Increasing Market Penetration In The U.S.
11.2.1.4 Improvements In Pen Needle Technologies To Eliminate Needlestick Injuries
11.2.1.5 Low Penetration Of Pen Injectors In The U.S. As Compared To Europe
11.2.2 Canada
11.2.2.1 High Diabetes Prevalence
11.2.2.2 Regulations For The Use Of Safety-Engineered Needles
11.2.2.3 Government Support For Pen Needles In Alberta
11.3 Europe
11.3.1 Germany
11.3.1.1 Regulatory Framework To Minimize Needlestick Injuries & Boost Use Of Safety-Engineered Devices
11.3.1.2 High Diabetes Prevalence And Reimbursement For Pen Needles
11.3.2 U.K.
11.3.2.1 Activities To Pool Funds For Diabetes Care & Research
11.3.3 France
11.3.3.1 Conferences And Exhibitions To Increase Exposure For Pen Needles Players In French Market
11.3.3.2 Higher Insurance Coverage And Increase In Aging Population And Affordability
11.3.4 Italy
11.3.4.1 Wide Regional Variations In Terms Of Benefits And Coverage To Slow Growth In Italy
11.3.4.2 Awareness Campaigns For Diabetes In Italy To Propel The Market Growth
11.3.5 Spain
11.3.5.1 Large Pool Of Diabetic Population, Regulations Mandating The Use Of Safety Pen Needles
11.3.6 Rest Of Europe
11.3.6.1 High Diabetes Prevalence In Russia, Poland, Romania, And Ukraine
11.4 Asia
11.4.1 Japan
11.4.1.1 High Adoption Of Insulin Pens And Approval Of Injectable Insulin
11.4.2 China
11.4.2.1 Growing Presence Of Global And Local Players In China
11.4.2.2 High Diabetes Incidence And Adoption Of Insulin Pens
11.4.2.3 High Reuse Rate & Lack Of Reimbursement To Limit Market Growth
11.4.3 India
11.4.3.1 Growing Presence Of Global Players In India
11.4.3.2 Low Pen Needle Penetration, Lack Of Awareness To Restrain Market Growth
11.4.4 Rest Of Asia
11.4.4.1 Vietnam, A Potential Market For Pen Needles
11.4.4.2 Increase In Pen Needles Likely In Singapore & Malaysia
11.5 Rest Of The World (Row)
11.5.1 Latin America
11.5.1.1 Increasing Diabetic Population And Rising Awareness On Diabetes In Brazil
11.5.2 Pacific Countries
11.5.2.1 Amendments In Ndss To Increase Access To Diabetic Products In Australia
11.5.2.2 Favorable Reimbursement Scenario And Presence Of Charity Organizations In New Zealand
11.5.3 Middle East & Africa
11.5.3.1 Presence Of Local & International Pen Needle Manufacturers And Rising Awareness On Pen Needles To Bolster The Market
11.5.3.2 Increasing Diabetic Population, Rising Awareness On Diabetes

12 Pen Needle Distributor List

13 Competitive Landscape
13.1 Overview
13.2 Market Share Analysis
13.2.1 Introduction
13.2.2 Becton, Dickinson & Co.
13.2.3 Novo Nordisk A/S
13.2.4 Ypsomed Holding Ag
13.2.5 Others
13.3 Competitive Situation And Trends
13.3.1 Marketing And Promotion
13.3.2 Expansion
13.3.3 Product Launch
13.3.4 Others

14 Company Profiles(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MNM View) -
14.1 Introduction
14.2 Becton, Dickinson And Company
14.3 Novo Nordisk A/S
14.4 Ypsomed Holding Ag
14.5 Owen Mumford, Ltd.
14.6 Htl-Strefa S.A.
14.7 B. Braun Melsungen
14.8 Terumo Corporation
14.9 Ultimed, Inc. (Ldi, Ltd.)
14.10 Allison Medical, Inc.
14.11 Artsana S.P.A.

15 Appendix

List Of Tables

Table 1 10 Countries/Territories With The Highest Number Of Diabetics(20-79 Years), 2015 & 2040
Table 2 Favorable Reimbursement Environment In North America & Europe And Growing Diabetic Population To Drive The Growth Of The Global Pen Needles Market
Table 3 Poor Reimbursement Structure In Developing Countries Is Restraining The Growth Of The Pen Needles Market
Table 4 Safety Needles To Offer Significant Growth Opportunities In The Pen Needles Market
Table 5 Minimizing The Reuse Of Pen Needles Is A Major Market Challenge
Table 6 Evaluation Parameters And Scores
Table 7 Competitive Intensity For Bd
Table 8 Competitive Intensity For Novo Nordisk
Table 9 Competitive Intensity For Ypsomed
Table 10 Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 11 Pen Needles Market Size, By Type, 2014-2021 (Million Units)
Table 12 Standard Pen Needles Market Size, By Region, 2014-2021 (USD Million)
Table 13 Standard Pen Needles Market Size, By Region, 2014-2021 (Million Units)
Table 14 Safety Pen Needles Market Size, By Region, 2014-2021 (USD Million)
Table 15 Standard Pen Needles Market Size, By Region, 2014-2021 (Million Units)
Table 16 Pen Needles Market Size, By Length, 2016-2021 (USD Million)
Table 17 4Mm Pen Needles Market Size, By Region, 2014-2021 (USD Million)
Table 18 5Mm Pen Needles Market Size, By Region, 2014-2021 (USD Million)
Table 19 6Mm Pen Needles Market Size, By Region, 2014-2021 (USD Million)
Table 20 8Mm Pen Needles Market Size, By Region, 2014-2021 (USD Million)
Table 21 10Mm Pen Needles Market Size, By Region, 2014-2021 (USD Million)
Table 22 12Mm Pen Needles Market Size, By Region, 2014-2021 (USD Million)
Table 23 Pen Needles Market Size, By Therapy, 2014-2021 (USD Million)
Table 24 Indicative List Of Insulin Developments By Various Companies
Table 25 Insulin Market Size, By Region, 2014-2021 (USD Million)
Table 26 Glp-1 Market Size, By Region, 2014-2021 (USD Million)
Table 27 Growth Hormones Market Size, By Region, 2014-2021 USD Million)
Table 28 Pen Needles Market Size, By Mode Of Purchase,2014-2021 (USD Million)
Table 29 Pen Needles Market Size For Retail Purchases, By Region,2014-2021 (USD Million)
Table 30 Indicative List Of Regulatory Acts
Table 31 Pen Needles Market Size For Non-Retail Purchases, By Region,2014-2021 (USD Million)
Table 32 Pen Needles Market Size, By Region, 2014-2021 (USD Million)
Table 33 Pen Needles Market Size, By Region, 2014-2021 (Million Units)
Table 34 North America: Pen Needles Market Size, By Country,2014-2021 (USD Million)
Table 35 North America: Pen Needles Market Size, By Type,2014-2021 (USD Million)
Table 36 North America: Pen Needles Market Size, By Type,2014-2021 (Million Units)
Table 37 North America: Pen Needles Market Size, By Needle Length,2014-2021 (USD Million)
Table 38 North America: Pen Needles Market Size, By Therapy,2014-2021 (USD Million)
Table 39 North America: Pen Needles Market Size, By Mode Of Purchase,2014-2021 (USD Million)
Table 40 Estimated Cost-Savings From The Use Of Safety- Engineered Devices In The U.S.
Table 41 U.S.: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 42 U.S.: Pen Needles Market Size, By Type, 2014-2021 (Million Units)
Table 43 Canada: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 44 Canada: Pen Needles Market Size, By Type, 2014-2021 (Million Units)
Table 45 Europe: Pen Needles Market Size, By Country, 2014-2021 (USD Million)
Table 46 Europe: Pen Needles Market Size, By Country,2014-2021 (Million Un Its)
Table 47 Europe: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 48 Europe: Pen Needles Market Size, By Type, 2014-2021 (Million Units)
Table 49 Europe: Pen Needles Market Size, By Length, 2014-2021 (USD Million)
Table 50 Europe: Pen Needles Market Size, By Therapy, 2014-2021 (USD Million)
Table 51 Europe: Pen Needles Market Size, By Mode Of Purchase,2014-2021 (USD Million)
Table 52 Estimated Annual Number Of Nsi-Caused Infections In German Hospitals
Table 53 Germany: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 54 Germany: Pen Needles Market Size, By Type, 2014-2021 (Million Units)
Table 55 Institutions That Received Funding Of More Than Gbp 100,000(USD 145,805)
Table 56 Highlights Of Diabetes U.K. Activities, 2013
Table 57 U.K.: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 58 U.K.: Pen Needles Market Size, By Type, 2014-2021 (Million Units)
Table 59 France: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 60 France: Pen Needles Market Size, By Type, 2014-2021 (Million Units)
Table 61 Highlights Of Awareness Campaign Conducted By Havas Pr & Idf In Italy
Table 62 Italy: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 63 Italy: Pen Needles Market Size, By Type, 2014-2021 (Million Units)
Table 64 Spain: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 65 Spain: Pen Needles Market Size, By Type, 2014-2021 (Million Units)
Table 66 European Countries With Highest Diabetic Cases And Diabetes-Related Deaths In 2015
Table 67 Roe: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 68 Roe: Pen Needles Market Size, By Type, 2014-2021 (Million Units)
Table 69 Asia: Pen Needles Market Size, By Country, 2014-2021 (USD Million)
Table 70 Asia: Pen Needles Market Size, By Country, 2014-2021 (Million Units)
Table 71 Asia: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 72 Asia: Pen Needles Market Size, By Type, 2014-2021 (Million Units)
Table 73 Asia: Pen Needles Market Size, By Needle Length,2014-2021 (USD Million)
Table 74 Asia: Pen Needles Market Size, By Therapy, 2014-2021 (USD Million)
Table 75 Asia: Pen Needles Market Size, By Mode Of Purchase,2014-2021 (USD Million)
Table 76 Japan: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 77 Japan: Pen Needles Market Size, By Type, 2014-2021 (Million Units)
Table 78 Indicative List Of Pen Needle Manufacturers In China
Table 79 China: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 80 China: Pen Needles Market Size, By Type, 2014-2021 (Million Units)
Table 81 India: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 82 India: Pen Needles Market Size, By Type, 2014-2021 (Thousand Units)
Table 83 Roa: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 84 Roa: Pen Needles Market Size, By Type, 2014-2021 (Thousand Units)
Table 85 Row: Pen Needles Market Size, By Region, 2014-2021 (USD Million)
Table 86 Row: Pen Needles Market Size, By Region, 2014-2021 (Million Units)
Table 87 Row: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 88 Row: Pen Needles Market Size, By Type, 2014-2021 (Thousand Units)
Table 89 Row: Pen Needles Market Size, By Length, 2014-2021 (USD Million)
Table 90 Row: Pen Needles Market Size, By Therapy, 2014-2021 (USD Million)
Table 91 Row: Pen Needles Market Size, By Mode Of Purchase, 2014-2021 (USD Million)
Table 92 Latin America: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 93 Latin America: Pen Needles Market Size, By Type, 2014-2021 (Thousand Units)
Table 94 Pen Needles Available In New Zealand
Table 95 Pacific Countries: Pen Needles Market Size, By Type,2014-2021 (USD Million)
Table 96 Pacific Countries: Pen Needles Market Size, By Type, 2014-2021 (Thousand Units)
Table 97 Middle East & Africa: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 98 Middle East & Africa: Pen Needles Market Size, By Type, 2014-2021 (Thousand Units)
Table 99 Marketing And Promotion, 2014-2016
Table 100 Expansion, 2013-2015
Table 101 Product Launch, 2013-2015
Table 102 Others, 2013-2016

List Of Figures

Figure 1 Global Pen Needles Market Segmentation
Figure 2 Global Pen Needles Market: Research Methodology Steps
Figure 3 Breakdown Of Primary Interviews: By Company Type, Designation, And Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Standard Pen Needles Market To Contribute To The Larger Share Of The Pen Needles Market In 2016
Figure 8 8Mm Pen Needles Are Estimated To Command The Largest Share In 2016
Figure 9 Insulin Therapy Segment Is Expected To Continue To Dominate The Pen Needles Market During The Forecast Period (2016-2021)
Figure 10 Asia Is Slated To Witness The Highest Growth In The Pen Needles Market During The Forecast Period (2016-2021)
Figure 11 Asian Pen Needles Market To Register Highest Growth In The Forecast Period
Figure 12 Europe To Dominate The Global Pen Needles Market
Figure 13 Safety Pen Needles Segment To Grow At The Highest Rate
Figure 14 8Mm Pen Needles Segment To Command The Highest Market Size In 2016
Figure 15 Retail Segment Expected To Command The Largest Size Of The Pen Needles Market In 2021
Figure 16 Asia To Register Highest Growth Rate From 2016 To 2021
Figure 17 Pen Needles Market Segmentation
Figure 18 Pen Needles Market: Drivers, Restraints, Opportunities, & Challenges
Figure 19 Porter’S Five Forces Analysis: Pen Needles Market
Figure 20 Scoring Methodology
Figure 21 Comparison Of Competitive Intensity Scores: Bd, Novo Nordisk, And Ypsomed
Figure 22 Relative Positioning Of Companies Based On Competitive Intensity Scores And Pen Needle Focus
Figure 23 Safety Pen Needles By Bd And Standard Pen Needles By Novo Nordisk Are Premium-Priced
Figure 24 Bd Has A Robust Portfolio Of Both Standard And Safety Pen Needles
Figure 25 Bd Has More Focus On Innovation In Its Pen Needles Business
Figure 26 Bd Has The Highest Production Capacity Of Pen Needles
Figure 27 Bd And Novo Nordisk Have A Strong Geographic Presence
Figure 28 Bd And Novo Nordisk Showcase High Focus On Marketing And Promotional Activities
Figure 29 Novo Nordisk Has High Focus On Diabetes Education And Awareness
Figure 30 Novo Nordisk Aggressively Follows The Growth Strategy Of Partnerships And Agreements
Figure 31 Novo Nordisk Is The Most Experienced Firm In Pen Needles Market
Figure 32 Bd, Novo Nordisk, And Ypsomed Equally Exhibit High Compliance With Industry Standards
Figure 33 Indicative List Of Key Players (Manufacturers/Marketers) In The Global Pen Needles Market
Figure 34 Indicative List Of Players (Manufacturers/Marketers) In Pen Needles Market In Specific Countries
Figure 35 Standard Pen Needles Segment To Command The Largest Market Size In 2016
Figure 36 Availability Of Pen Needles, By Company
Figure 37 8Mm Pen Needles Segment To Command The Largest Market Size In 2016 And 2021
Figure 38 Insulin Therapy Segment To Command The Largest Size Of Pen Needles Market In 2016
Figure 39 Retail Purchases Segment To Command The Largest Market Share In 2016
Figure 40 Europe To Command The Largest Share Of The Global Pen Needles Market In 2016
Figure 41 U.S. To Witness Highest Growth In The North American Pen Needles Market From 2016 To 2020
Figure 42 European Pen Needles Market Snapshot
Figure 43 Diabetes U.K.: Funds Raised Vs. Funds Invested
Figure 44 China To Witness Highest Growth In The Asian Pen Needles Market From 2016 To 2021
Figure 45 Market Share Analysis, By Key Player, 2015
Figure 46 Growth Strategies, By Company
Figure 47 Companies Adopted Marketing & Promotion As The Key Growth Strategy From 2013-2016
Figure 48 Geographic Revenue Mix Of Top Market Players
Figure 49 Becton, Dickinson & Company: Company Snapshot
Figure 50 Novo Nordisk A/S: Company Snapshot
Figure 51 Ypsomed Holding Ag: Company Snapshot
Figure 52 B. Braun Melsungen: Company Snapshot
Figure 53 Terumo Corporation: Company Snapshot
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Allison Medical, Inc.
  • Artsana S.P.A.
  • B. Braun Melsungen
  • Htl-Strefa S.A.
  • Novo Nordisk A/S
  • Owen Mumford, Ltd.
  • MORE
The market is segmented on the basis of type, needle length, therapy, and mode of purchase. By type, the market is categorized into standard and safety pen needles. The standard pen needles segment is expected to account for the largest share of the market in 2016. The large share of this segment can be attributed to the low cost of these instruments and increasing adoption in emerging nations. However, the safety pen needles segment is projected to grow at the highest CAGR during the forecast period.

The pen needles market, based on needle length, is segmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. The 8mm needle length segment is expected to account for the largest share of the market in 2016. However, pen needles with 4mm length are expected to grow at the highest CAGR in the market, by needle length. Growth in this segment can be attributed to the increasing adoption of pen needles of shorter length and technological advancements in 4mm pen needles.

On the basis of therapy, the pen needles market is segmented into insulin therapy, glucagon-like-peptide-1 (GLP-1) therapy, and growth hormone therapy. The insulin therapy segment is expected to account for the largest share of the market in 2016, and is projected to grow at the highest CAGR during the forecast period. Factors responsible for the growth of insulin therapy during the forecast period include increasing diabetes population, favorable reimbursement scenario and strong government support in selected countries, and awareness campaigns and conferences to improve diabetes care and adoption of pen needles.

Based on mode of purchase, the pen needles market is segmented into retail and non-retail modes of purchase. The retail mode of purchase segment is expected to account for the largest share of the market, and is projected to grow at the highest CAGR during the forecast period. The large share of the retail mode of purchase segment can be attributed to availability of discounts at retail outlets and pharmacies; availability of free samples; and increasing ease of purchase through mail ordering and online ordering of pen needles.

On the basis of regions, the pen needles market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Europe is expected to account for the largest share of the market in 2016. The large share of Europe can be attributed to the EU’s directive on prevention of sharp injuries in hospitals and the healthcare sector; changes in the regulatory framework in Germany to minimize needlestick injuries; high incidence of diabetes across European nations; activities undertaken in the U.K. to pool funds for diabetes care and research; higher insurance coverage and increase in aging population and affordability in France; awareness campaigns for diabetes in Italy; and the high export potential of injectable drug delivery devices in Spain. However, the Asian region is expected to grow at the highest CAGR during the forecast period.

Scope of the Report:

This research report categorizes the pen needles market into the following segments and sub-segments:

Pen Needles Market, by Type
- Standard Pen Needles
- Safety Pen Needles

Pen Needles Market, by Needle Length
- 4mm
- 5mm
- 6mm
- 8mm
- 10mm
- 12mm

Pen Needles Market, by Therapy
- Insulin
- Glucagon-like-Peptide-1 (GLP-1)
- Growth Hormone

Pen Needles Market, by Mode of Purchase
- Retail
- Non-retail

Pen Needles Market, by Region
North America
- U.S.
- Canada

Europe
- Germany
- France
- U.K.
- Spain
- Italy
- RoE

Asia
- Japan
- China
- India
- RoAPAC

RoW
- Latin America
- Pacific Countries
- Middle East and Africa
Note: Product cover images may vary from those shown
5 of 5
  •  Allison Medical, Inc.
  •  Artsana S.P.A.
  •  B. Braun Melsungen
  •  Becton, Dickinson And Company
  •  Htl-Strefa S.A.
  •  Novo Nordisk A/S
  •  Owen Mumford, Ltd.
  •  Terumo Corporation
  •  Ultimed, Inc. (Ldi, Ltd.)
  •  Ypsomed Holding Ag
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll